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Ceramide is a Mediator of Apoptosis
in Retina Photoreceptors
Olga L. German, Gisela E. Miranda, Carolina E. Abrahan and Nora P. Rotstein
PURPOSE. The precise mechanisms involved in photoreceptor
apoptosis are still unclear. In the present study, the role of
ceramide, a sphingolipid precursor that induces apoptosis on
cellular stress, was investigated in relation to the activation of
cell death in photoreceptors.
METHODS. Rat retina neuronal cultures, with or without doco-
sahexaenoic acid (DHA), were treated with the ceramide ana-
logue acetylsphingosine (C2-ceramide), and with a glucosylce-
ramide synthase inhibitor. Ceramide synthesis in cultures
treated with the oxidant paraquat was evaluated with
[3H]palmitate. The effect of inhibitors of ceramide de novo
synthesis, fumonisin B1 and cycloserine, on photoreceptor
apoptosis was investigated. Apoptosis, mitochondrial mem-
brane potential, and Bcl-2 expression were determined.
RESULTS. Addition of C2-ceramide induced photoreceptor apo-
ptosis. Paraquat increased formation of [3H]ceramide in pho-
toreceptors, compared with the control, whereas inhibition of
ceramide synthesis, immediately before paraquat treatment,
prevented paraquat-induced photoreceptor apoptosis. Fumoni-
sin also reduced photoreceptor apoptosis during early devel-
opment in vitro. DHA, the retina major polyunsaturated fatty
acid, which protects photoreceptors from oxidative stress-
induced apoptosis, completely blocked C2-ceramide-induced
photoreceptor death, simultaneously increasing Bcl-2 expres-
sion. Inhibiting glucosylceramide synthase, which catalyzes
ceramide glucosylation, before ceramide or paraquat treatment
blocked DHA’s protective effect.
CONCLUSIONS. The results suggest that oxidative stress stimu-
lated an increase in ceramide levels that induced photorecep-
tor apoptosis. DHA prevented oxidative stress and ceramide
damage by upregulating Bcl-2 expression and glucosylating
ceramide, thus decreasing its intracellular concentration. This
shows for the first time that ceramide is a critical mediator for
triggering photoreceptor apoptosis in mammalian retina and
suggests that modulating ceramide levels may provide a ther-
apeutic tool for preventing photoreceptor death in neurode-
generative diseases. (Invest Ophthalmol Vis Sci. 2006;47:
1658–1668) DOI:10.1167/iovs.05-1310
Apoptosis of photoreceptors leads to retinal dysfunction inneurodegenerative disorders, such as retinitis pigmen-
tosa,1,2 by mechanisms still ill-defined. Oxidative stress has
been proposed to have a decisive role in activating this death;
it has been related to cone cell death in retinitis pigmentosa3;
antioxidants can ameliorate the progression of retinal neuro-
degeneration4,5; an early and sustained increase in intracellular
reactive oxygen species accompanies photoreceptor apoptosis
in vitro,6 whereas an increased expression of oxidative stress-
related genes is observed during the progression of retinal
neurodegeneration.7
We have recently shown that oxidative stress induced with
the oxidant paraquat (PQ), an anion superoxide generator,
triggers photoreceptor apoptosis in culture, and that loss of
mitochondrial membrane potential accompanies apoptotic
death.8 Avoidance of mitochondrial depolarization is crucial
for the prevention of photoreceptor death by trophic factors
such as docosahexaenoic acid (DHA).8–10
DHA is the most abundant polyunsaturated fatty acid in the
retina and is particularly enriched in photoreceptors. Essential
for proper development of vision,11 its deficiency leads to loss
of visual acuity12 and alterations in the electroretinogram.13–15
DHA has been shown to protect retina photoreceptors from
apoptosis during early development in culture9,10,16,17 and on
oxidative stress.8 DHA prevents oxidative stress-induced apo-
ptosis of photoreceptors by increasing antiapoptotic protein
Bcl-2 levels. A similar mechanism is involved in DHA protection
of retinal pigment epithelial cells from oxidative stress.18 In
addition, DHA modulates Akt and downregulates caspase-3
activity to prevent apoptosis in a neuronal cell line.19,20
Information on which mediators participate in the induc-
tion of photoreceptor cell death is still lacking. Ceramide, a
sphingolipid metabolic precursor, is a bioactive lipid that has
been proposed to be an endogenous mediator of apopto-
sis.21–23 Ceramide is actively involved in the triggering of
apoptosis in many cell systems, including neurons.24,25 An
increase in ceramide intracellular levels26,27 has been shown to
occur on hypoxia, trophic factor removal, treatment with che-
motherapeutic agents, heat, UV radiation, and other stress
signals, such as oxidative stress.28,29 Ceramide levels depend
on the activity of several enzymes that participate in its syn-
thesis and catabolism. The increase in ceramide in response to
apoptotic stimuli may arise from hydrolysis of sphingomyelin
due to stimulation of sphingomyelinases,25,30,31 through de
novo biosynthesis27,32 or from the combined stimulation of
both pathways.33 In turn, several biochemical reactions lead to
the disappearance of ceramide: its hydrolysis catalyzed by
ceramidases, sphingomyelin resynthesis, or ceramide glucosy-
lation.
Evidence linking ceramide with activation of apoptosis in
photoreceptors is scarce and indirect. Increased ceramide lev-
els have been found in brains of patients with the juvenile form
of Batten disease, in which neuronal apoptosis in the retina and
brain lead to blindness, seizures, and cognitive decline.34 Mod-
ulation of enzymes involved in sphingolipid metabolism sup-
pressed retinal degeneration in Drosophila translation mu-
tants.35 Of note, a mutation in a novel ceramide kinase gene
has been recently established as a cause of an autosomal reces-
sive form of retinitis pigmentosa,36 suggesting a direct link
between sphingolipid metabolism and human retinal degener-
ation.
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In this study, we investigated the involvement of ceramide
in the induction of photoreceptor apoptosis. Exogenous addi-
tion of C2-ceramide, a ceramide analogue, triggered photore-
ceptor apoptosis, whereas inhibition of de novo synthesis of
ceramide protected photoreceptors from oxidative stress-in-
duced apoptosis. We also demonstrated that DHA blocked
ceramide-induced apoptosis, and this protection not only in-
volved an increase in Bcl-2 expression but also a decrease in
ceramide levels through its metabolization to glucosylceram-
ide. As a whole, our results suggest that ceramide is a key
activator of photoreceptor apoptosis and that avoiding a cer-
amide increase or blocking ceramide’s effects may prevent
photoreceptor death after oxidative damage.
MATERIALS AND METHODS
Albino Wistar rats bred in our own colony were used in all the
experiments. All proceedings involving animals were performed in
accordance with the ARVO Statement for the Use of Animals in Oph-
thalmic and Vision Research. Plastic culture 35-mm diameter dishes
(NUNC) were purchased from Inter Med (Naperville, IL). Dulbecco’s
modified Eagle’s medium (DMEM) was from Invitrogen-Life Technolo-
gies (Gaithersburg, MD). Bovine serum albumin (Fraction V; fatty
acid-free; low endotoxin, tissue-culture tested), paraquat dichloride
(methyl viologen, 1,1-dimethyl-4,4-bipyridinium dichloride, PQ),
poly-DL-ornithine, trypsin, trypsin inhibitor, transferrin, hydrocorti-
sone, putrescine, insulin, polyornithine, selenium, gentamicin, 4,6-
diamidino-2-phenylindole (DAPI), monoclonal anti-syntaxin clone
HPC-1, docosahexaenoic acid, and paraformaldehyde were from Sig-
ma-Aldrich (St. Louis, MO). C2-acetylsphingosine (C2-ceramide), fumo-
nisin B1 (FB), dihydroceramide, DL-threo-1-phenyl-2-palmitoylamino-3-
morpholino-1-propanol-HCl (PPMP), cycloserine, and kainic acid were
from Biomol (Plymouth Meeting, PA). A tyramide signal amplification
kit and [9,10-3H]palmitic acid (47 mCi/mmol) were from NEN (Boston,
MA). The secondary antibodies, Alexa 488-conjugated-goat anti-mouse
and a mitochondrial probe (MitoTracKer Red CMXRos) were from
Molecular Probes, Inc. (Eugene, OR). The monoclonal antibody to
Bcl-2 (sc-7382) was from Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA). The monoclonal antibody against rhodopsin, Rho4D2 was gener-
ously supplied by Robert Molday (University of British Columbia,
Vancouver, British Columbia, Canada). Solvents were HPLC grade, and
all other reagents were analytical grade.
Neuronal Cultures
Purified cultures of rat retinal neurons were prepared as previously
described.16,37,38 Approximately 0.5  105 cells/cm2 were seeded on
35-mm diameter dishes that had previously been sequentially treated
with polyornithine and Schwannoma-conditioned medium.39
Addition of Docosahexaenoic Acid
Docosahexaenoic acid (DHA), at a 6.7-M final concentration, was
added at day 1 in culture, complexed with bovine serum albumin
(BSA), in a 2:1 (fatty acid: BSA) molar ratio.38 The same volume and
concentration of a BSA solution was simultaneously added to control
cultures.
Addition of C2-Ceramide
Because of its extremely hydrophobic characteristics, natural, long-
chain ceramides are frequently replaced in experiments in vitro by
short acyl chain ceramides such as acetylsphingosine (C2-ceramide),
which is more soluble and cell permeable. C2-ceramide is naturally
synthesized in cells, its addition to cell cultures has been shown to
produce apoptosis in several cell systems,40,41 and the use of inhibitors
that lead to ceramide intracellular accumulation have produced similar
results.42 C2-ceramide was added to the cultures at day 3 in vitro, in
concentrations ranging from 5 to 25 M (final medium concentration),
in an ethanol-calcium (1:8) magnesium-free solution. The same volume
of the vehicle used for solubilizing C2-ceramide, or the same concen-
tration of dihydroceramide was added to the control. Cultures were
then incubated for 24 hours before fixation. In every case, ethanol final
concentration in the incubation medium was lower than 0.1%. In
subsequent experiments, a 10-M C2-ceramide concentration was
used.
Inhibition of Ceramide Synthesis
To test whether ceramide participated in oxidative stress-induced
apoptosis, we blocked the synthesis of sphingolipids with FB, a well-
known and extensively used inhibitor of ceramide synthase. Two
different series of experiments were performed. First, to deplete the
neurons of sphingolipids, FB was added to the culture medium at day
0, 3 hours after the cells were seeded, at concentrations of 25- and
50-M.25 To induce oxidative stress, the oxidant PQ, at a 48-M
concentration, was added to the cultures at day 3.8 In a second series
of experiments, designed to block only de novo synthesis of ceramide,
25 M FB was added at day 3. Cultures were returned to the incubator
for 30 minutes and then treated with PQ.
To establish further the role of ceramide in triggering photorecep-
tor apoptosis, additional experiments were performed with cy-
closerine, a widely used inhibitor of serine palmitoyltransferase, the
enzyme catalyzing the first step in ceramide de novo synthesis. Con-
centrations ranging from 0.06 to 2 mM were evaluated, and a 0.25-mM
concentration was chosen for the experiments, because higher cy-
closerine concentrations had a toxic effect and lower concentrations
had less or no inhibitory effect. Cycloserine was added to the cultures
at day 3, and PQ was added 2 hours later.
To evaluate whether ceramide production was involved in apopto-
sis induction during development, 25 M FB was added to the cultures
3 hours after the cells were seeded. After 6 days in vitro, cultures were
fixed, and the amount of apoptotic photoreceptors was determined.
Inhibition of Glucosylceramide Synthase
To determine whether this enzyme was involved in the protective
effect of DHA, DL-threo-1-phenyl-2 palmitoylamino-3-morpholino-1-pro-
panol-HCl (PPMP), an inhibitor of glucosylceramide synthase, was
added at a 10-M concentration to 3-day cultures, with or without
DHA. After a 30-minute incubation, cultures were treated with 10 M
C2-ceramide for 24 hours. Cultures having PPMP, PPMP plus DHA or
PPMP plus dihydroceramide were used as the control. In a different
series of experiments, cultures with or without DHA were treated with
PPMP and after 30 minutes with PQ.
Paraquat Addition
PQ (48 M final concentration in the incubation medium, in a calcium-
magnesium–free solution) was added to 3-day cultures. Neurons were
then incubated for 24 hours before fixation.
Neuronal Incubation with [3H]palmitate
To determine whether endogenous ceramide levels would increase
after PQ addition, neuronal cultures were incubated with [3H]palmi-
tate. At day 3, neuronal cultures were treated with kainic acid (0.25
mM) for 2 hours, to induce amacrine cell death.43 [3H]palmitate (0.7
Ci/dish) was dried in nitrogen, resuspended in the medium used for
neuronal incubation, complexed with BSA (fatty acid-BSA, 2:1 molar
ratio), and added to the cultures. After 30 minutes, cells were treated
with PQ for 2 or 4 hours. The incubation medium was then removed,
and neuronal lipids were extracted.
Lipid Extraction and Separation
Cells were washed twice with 1 mL ice-cold phosphate-buffered saline
(PBS; 0.9% NaCl in 0.01 M NaH2PO4 [pH 7.4]), and then scraped and
transferred in PBS and to a glass tube. Cells were centrifuged at 1000 rpm,
for 10 minutes, the supernatant was removed, and the lipids were ex-
tracted according to Folch et al.44 Mild alkaline treatment was then
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performed, incubating lipid extracts with 1 M NaOH in a methanol
solution for 10 minutes at 50°C. Incubation was stopped by adding an
equal volume of 1 N HCl, and chloroform. Lipids were then separated by
thin-layer chromatography (TLC), using a combination of two solvent
systems, chloroform-methanol-acetic acid- H2O (20:15:1.4:0.8) up to one
third of the plate’s length, and chloroform-methanol-acetic acid (190:9:1)
to the top. Unlabeled lipids prepared from bovine retina were added as
carriers to the samples. Lipid spots, visualized with I2 vapors, were iden-
tified with standards and then scraped to vials. The incorporated radioac-
tivity was determined by liquid scintillation counting.
Immunocytochemical Methods
Cultures were fixed for at least 1 hour with 2% paraformaldehyde in
PBS, at room temperature, followed by permeation with Triton X-100
(0.1% in PBS) for 15 minutes. Photoreceptor cells were identified by
immunocytochemistry with the monoclonal antibody Rho4D2, by
their morphology, and other criteria as previously described.9,10 Ama-
crine cells were identified with the anti-syntaxin monoclonal antibody,
HPC-1, as described.38 Alexa 488-conjugated goat anti-mouse was used
as the secondary antibody. Tyramide signal amplification was occasion-
ally used to improve visualization, according to the manufacturer’s
procedure. Controls for immunocytochemistry were performed by
omitting either the primary or the secondary antibody. Apoptosis was
determined by evaluating integrity of the nuclei after staining cell
nuclei with DAPI, a fluorescent dye that binds to DNA. Briefly, cells
were permeated with 0.1% Triton X-100 in PBS, washed with PBS and
incubated with DAPI for 20 minutes. Cells were considered to be
apoptotic when they showed either fragmented or condensed (py-
knotic) nuclei. The amount of apoptotic photoreceptors or amacrine
cells was counted in cultures double-labeled with DAPI and with either
Rho4D2 or HPC-1, to identify unambiguously the cells as either pho-
toreceptors or amacrine neurons, respectively, and thus establish the
total amount of each cell type. The percentage of apoptotic photore-
ceptors and amacrine neurons was then calculated, taking into account
the percentage of Rho4D2- and HPC-1-labeled cells, respectively. To
assess the amount of cells preserving their mitochondrial membrane
potential, cultures were incubated for 30 minutes before fixation with
the fluorescent probe (0.1 g/mL; MitoTracker; Molecular Probes),
and the amount of photoreceptors displaying fluorescent mitochondria
with respect to the total number of photoreceptors was determined.
The number of photoreceptors expressing Bcl-2 with respect to the
total number of photoreceptors was quantified by immunocytochem-
istry with a specific monoclonal antibody.
Statistical Analysis
For cytochemical studies, 10 fields per sample, randomly chosen, were
analyzed in each case. Each value represents the average of two or
three experiments, with three to four dishes for each condition  SD.
Statistical significance (P  0.05) was determined by Student’s two-
tailed t-test.
RESULTS
Effect of Addition of C2-ceramide on Induction of
Apoptosis in Retinal Neurons
To investigate whether ceramide may provoke cell death in
retinal neurons, we treated neuronal cultures with 10 M
C2-ceramide for 24 hours. This treatment induced the apopto-
sis of both photoreceptors (Fig. 1) and amacrine neurons.
Although most photoreceptors in control conditions had intact
nuclei and showed a normal morphology (Figs. 1A, 1C, 1E), the
addition of ceramide prompted large alterations in neuronal
morphology, retraction and loss of neurites, and nuclear frag-
mentation (Figs. 1B, 1D, 1F). The percentage of apoptotic
photoreceptors doubled on addition of ceramide, increasing
from approximately 27% in the control to almost 50% in cer-
amide-treated cultures (Fig. 2A). C2-ceramide also triggered
apoptosis in amacrine neurons, which increased from 5% to
35%, in control and ceramide-treated cultures, respectively
(Fig. 2A). Dihydroceramide, which has a similar chemical struc-
ture, uptake, and metabolism to that of ceramide, but lacks its
biological action, had no effect on neuronal apoptosis.
C2-ceramide also affected mitochondrial membrane poten-
tial. In control and dihydroceramide-treated cultures, approxi-
mately 60% of photoreceptors retained mitochondrial mem-
brane potential, whereas after treatment with 10 M C2-
ceramide only 30% still had intact, functional mitochondria
(Fig. 2B). Amacrine neurons retaining mitochondrial mem-
brane potential decreased from approximately 90% in the con-
trol to almost 50% in ceramide-treated cultures.
Retina neurons, cultured in a chemically defined medium
without photoreceptor trophic factors, were prone to ceram-
ide-induced apoptosis. Even a small (5 M) concentration led
to neuronal death. Neuronal apoptosis increased with higher
ceramide concentrations (Fig. 2C). Apoptotic photoreceptors
increased from less than 40% to more than 80%, and apoptotic
amacrine cells augmented from 20% to approximately 60%
when C2-ceramide concentration increased from 5 to 25 M.
At a 50-M C2-ceramide concentration, almost all neurons
were apoptotic and detached from the substratum.
Effect of PQ on [3H]ceramide Synthesis
in Photoreceptors
To evaluate directly whether oxidative stress increases endog-
enous ceramide levels, we measured ceramide production in
FIGURE 1. Addition of C2-ceramide to retina photoreceptors in cul-
ture. (A, B) Phase and (C–F) fluorescence photomicrographs of neu-
ronal cultures treated at day 3 (A, C, E) without or (B, D, F) with 10
M C2-ceramide for 24 hours. (C, D) Nuclei labeled with the DNA
probe DAPI. (E, F) Photoreceptors identified with the monoclonal
antibody Rho4D2. Most photoreceptors in control cultures had intact
nuclei (A, C, E, arrowheads), whereas C2-ceramide increased the
amount of photoreceptors with fragmented nuclei (B, D, F, arrows).
Note the retracting neurite in an apoptotic photoreceptor after cer-
amide treatment (B, F, open arrows). Scale bar, 10 m.
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photoreceptors on PQ treatment by pulse-labeling neuronal
cells with [3H]palmitate. Cultures were treated with kainic acid
for 2 hours, to eliminate most amacrine neurons43 and estab-
lish ceramide synthesis only in photoreceptors. We then added
[3H]palmitate, and 30 minutes later, PQ. Similar amounts of
[3H]palmitate were rapidly incorporated in the cells and ester-
ified in neuronal lipids in PQ-treated and untreated cultures
(not shown). Two hours after PQ addition, a clear increase was
observed in labeled ceramide (Fig. 3A). The amount of [3H]ce-
ramide in PQ-treated cultures was approximately twice that in
the control. This difference persisted after 4 hours of PQ
treatment. In contrast, the incorporation of [3H]palmitate into
sphingomyelin was very low, as had been observed.17 Both in
controls and PQ-treated cultures, [3H]sphingomyelin (SPM)
levels were unaffected by the addition of PQ (Fig. 3B). Previous
findings from our laboratory showed that after 24 hours of PQ
treatment, the amount of apoptotic photoreceptors signifi-
cantly increased.8 Evaluation of photoreceptor apoptosis per-
formed in parallel at the incubation times used for analyzing
ceramide labeling showed that the increase in [3H]ceramide
corresponded with the onset of photoreceptor apoptosis (Fig.
3C). After 2 or 4 hours of PQ, the percentage of apoptotic
photoreceptors in PQ-treated cultures was already slightly but
significantly higher than in the control.
Experiments adding [3H]palmitate at day 1 in culture also
showed that the amount of labeled sphingomyelin was much
smaller than that of labeled ceramide, and was not diminished
by PQ addition (not shown).This suggests that, in basal condi-
tions, synthesis of ceramide in retina cultured neurons was
more active than that of sphingomyelin. PQ induced a rapid
accumulation of ceramide, which was consistent with the
activation of photoreceptor apoptosis, without decreasing
[3H]sphingomyelin levels, suggesting that ceramide is formed
FIGURE 2. Effect of C2-ceramide on apoptosis and mitochondrial
membrane potential in photoreceptors and amacrine neurons. Three-
day neuronal cultures were treated with 10 M C2-ceramide (Cer) or
dihydroceramide (DHC), or with the solution used as a vehicle for
preparing the sphingolipid solutions () for 24 hours. (A) The per-
centage of apoptotic photoreceptors and amacrine neurons was deter-
mined by analyzing nuclei integrity with DAPI. (B) The percentage of
neurons preserving mitochondrial membrane potential was quantified
with a fluorescent probe. *Statistically significant differences, com-
pared with the control (P  0.05). (C) Concentrations of C2-ceramide
ranging from 5 to 25 M were added to neuronal cultures, and the
percentage of apoptotic photoreceptor (f) and amacrine neurons (E)
was determined after 24 hours.
FIGURE 3. Accumulation of [3H]ceramide in photoreceptors induced
by PQ treatment. Three-day neuronal cultures were treated for 2 hours
with 0.25 mM kainic acid, to eliminate amacrine neurons, and then
were supplemented with 0.7 Ci/dish [3H]palmitate. After 30 minutes,
the cultures were left without (Control) or treated with 48 M para-
quat (PQ) for 2 or 4 hours. Cells were then scraped, for lipid extraction
and separation by TLC. Simultaneously, photoreceptor apoptosis was
determined at both incubation times. (A, B) The amount of [3H]cer-
amide and [3H]sphingomyelin (SPM) formed in control and PQ-treated
cultures. (C) Photoreceptor apoptosis (%) after 2 and 4 hours of
incubation without or with PQ. Each bar is the average of results
obtained from three different samples. Data are representative of three
separate experiments. *Statistically significant difference, compared
with the control (P  0.05).
IOVS, April 2006, Vol. 47, No. 4 Ceramide as a Mediator of Photoreceptor Apoptosis 1661
by de novo biosynthesis and not from breakdown of sphingo-
myelin.
Effect of Inhibiting Ceramide Synthesis on
PQ-Induced Apoptosis
To evaluate whether this increase in ceramide levels partici-
pated in triggering oxidative stress-induced apoptosis, the ef-
fect of different inhibitors of ceramide synthesis on photore-
ceptor apoptosis was evaluated separately. In initial
experiments, cells were treated with FB, an inhibitor of cer-
amide and sphingolipid de novo synthesis, approximately 2 to
3 hours after they were seeded. Because neuronal cells still
proliferate for the first 2 days in culture,45 FB causes a deple-
tion of sphingolipids, both sphingomyelin and ceramide, in
these cells. Hence, if PQ induced the production of ceramide
either by de novo synthesis or by sphingomyelin hydrolysis,
this production would be substantially reduced. After a 24-hour
treatment with PQ, cultures lacking FB showed the dramatic
changes in cell morphology that accompany oxidative injury
(Figs. 4A, 4C, 4E), as previously described.8 Cells lost their
characteristic morphology and acquired a round appearance,
with almost no neurites (Fig. 4A). They showed pyknotic or
fragmented nuclei, and most of them lost mitochondrial mem-
brane integrity (Figs. 4C, 4E). In control cultures, FB addition
had no toxic effects and did not affect neuronal survival (Fig.
4G), suggesting that lack of sphingolipid synthesis had no
effect on early neuronal development. In both control and
FB-supplemented cultures, less than 25% of photoreceptors
were apoptotic, compared with more than 60% in PQ-treated
cultures (Fig. 4G;8). In cultures supplemented with FB at day 0
and then treated with PQ, FB notably protected photorecep-
tors, which maintained their morphology, showed intact neu-
rites, and preserved both nuclei integrity and mitochondrial
membrane potential (Figs. 4B, 4D, 4F). FB addition, at either 25
or 50 M at day 0, substantially diminished photoreceptor
apoptosis. Even after PQ treatment, photoreceptor apoptosis
in these cultures was the same as in control conditions (Fig.
4G).
To establish whether the increase in ceramide was due to
sphingomyelin hydrolysis by sphingomyelinases or to de novo
synthesis, 25 M FB was added to the cultures at day 3, only 30
minutes before PQ treatment. This late addition would only
block de novo synthesis, without decreasing sphingomyelin
content, and ceramide production from breakdown of sphin-
gomyelin would still be possible. The FB protective effect was
the same as that found with addition of FB at day 0. Photore-
ceptor apoptosis decreased from more than 60% in PQ-treated
cultures lacking FB to approximately 26% in cultures treated
with FB before the addition of PQ (Fig. 5A), a value similar to
that in control conditions.
In both control and FB-supplemented cultures more than
60% of the photoreceptors retained their mitochondrial mem-
brane potential (Fig. 5B), a percentage that decreased to ap-
proximately 20% with PQ treatment. Addition of FB prevented
mitochondrial depolarization after PQ treatment. The percent-
age of photoreceptors retaining mitochondrial membrane po-
tential after addition of PQ to FB-supplemented cultures was
similar to that in the control. Hence, blocking ceramide pro-
duction completely inhibited photoreceptor apoptosis in-
duced by oxidative stress, precluding mitochondrial depolar-
ization.
FB was not so effective in preventing amacrine cell apopto-
sis induced by oxidative stress. Apoptotic amacrine cells, less
than 5% of total amacrine neurons in the control, increased to
46% after PQ treatment. When FB was added at day 0, apopto-
sis of amacrine neurons decreased to approximately 30% with
PQ treatment (Fig. 6A), but did not reach the level in control
conditions, as was the case with the photoreceptors (Fig. 5A).
The addition of FB at day 3, just before PQ treatment, had no
protective effect on PQ-induced apoptosis of amacrine cells
(Fig. 6B). These results suggest that ceramide is not the major
mediator in the triggering of amacrine cell apoptosis.
FIGURE 4. The effect of the addition of FB at day 0 in vitro on
photoreceptor apoptosis induced by oxidative stress. Neuronal cul-
tures were left without (left) or treated with (right) 25 M FB, 3 hours
after the cells were seeded, and at day 3 with 48 M PQ for 24 hours.
(A, B) Phase contrast and (C–F) fluorescence micrographs showing (C,
D) nuclei labeled with DAPI and (E, F) mitochondria labeled with a
mitochondrial probe. In PQ-treated cultures lacking FB (A, C, E) most
of the photoreceptors were apoptotic (arrows), showed fragmented
nuclei (C), and had a pale, fluorescent appearance, indicating mito-
chondrial depolarization (E). (B, D, F) The addition of FB promoted
photoreceptor survival (arrowheads), shown by intact nuclei (D) and
intensely fluorescent mitochondria, indicating the preservation of their
transmembrane potential (F). Scale bar, 10 m. (G) Neuronal cultures
were left without () or treated with 25 and 50 M FB 3 hours after
the cells were seeded, and then were treated at day 3 with PQ
(FBPQ). Apoptosis was determined, as previously described. *Statis-
tically significant difference, compared with the control (P  0.05).
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To confirm that ceramide accumulation mediated PQ-in-
duced apoptosis, and that this ceramide is produced by de
novo biosynthesis, we assessed the effect of inhibiting the first
step of this pathway on PQ-treated cultures. De novo synthesis
of ceramide starts with palmitate conversion to palmitoyl-CoA,
which condenses with serine to form keto-dihydrosphin-
gosine, a reaction catalyzed by serine palmitoyltransferase.
Dihydrosphingosine and dihydroceramide are subsequently
formed, the latter through the activity of (dihydro)ceramide
synthase, which is inhibited with FB. However, ceramide may
also be synthesized by the recycling/salvage pathway, by direct
N-linkage of palmitoyl-CoA to sphingosine, also through the
activity of ceramide synthase. Hence, the blockade of ceramide
synthase cannot discriminate which of these two pathways is
involved in ceramide synthesis in photoreceptors. To distin-
guish between them, cultures were treated with cycloserine,
an inhibitor of serine palmitoyltransferase. Addition of cy-
closerine completely prevented photoreceptor death on treat-
ment with PQ, strikingly reducing the percentage of apoptotic
photoreceptors, when compared with PQ-treated cultures
without cycloserine (Fig. 7A). Photoreceptor apoptosis in cul-
tures with cycloserine and PQ was virtually the same as that in
the control. This suggests that PQ stimulated de novo synthe-
sis, increasing ceramide levels, and this increase induced pho-
toreceptor apoptosis. Cycloserine also prevented the loss of
mitochondrial membrane potential in PQ-treated photorecep-
tors (Fig. 7B), supporting the hypothesis that the increase in
ceramide levels was upstream of mitochondrial alterations.
Effect of FB on Photoreceptor Apoptosis during
Development In Vitro
In the culture conditions described herein, photoreceptors
developed normally for 3 to 4 days, and then started a degen-
erative pathway that proceeds by apoptosis, leading to the
death of more than 60% of these cells by day 6.16,38 Addition of
FB 3 hours after the cells were seeded markedly diminished
photoreceptor apoptosis by day 6. The amount of fragmented
or pyknotic nuclei in FB-supplemented cultures (Figs. 8C, 8D)
was much smaller than in controls lacking FB (Figs. 8A, 8B); the
percentage of apoptotic photoreceptors was reduced from
more than 66% in control conditions to approximately 44% in
FB-supplemented cultures (Fig. 8E). This suggests that inhibi-
tion of ceramide synthesis may prevent photoreceptor death
during early development in vitro.
FIGURE 5. The effect of FB added at day 3 on oxidative stress-induced
photoreceptor apoptosis. Three-day cultures were left without () or
supplemented with 25 M FB and 30 minutes later were treated with
48 M PQ (PQ or FBPQ, respectively) for 24 hours. (A) Percentage
of apoptotic photoreceptors. (B) Percentage of photoreceptors pre-
serving mitochondrial membrane potential. *Statistically significant dif-
ference, compared with the control (P  0.05).
FIGURE 6. Partial prevention of amacrine neuronal apoptosis by early
addition of FB. Neuronal cultures were left without () or were treated
with 25 M FB (A), 3 hours after the cells were seeded, or (B) at day
3 with FB, PQ, or FBPQ or nothing (). Amacrine neurons were
identified with HPC-1, an anti-syntaxin monoclonal antibody, and the
percentage of apoptotic cells was then determined. *Statistically sig-
nificant difference, compared with the control (P  0.05).
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Protective Effect of DHA on Ceramide-Induced
Apoptosis of Photoreceptors
Because DHA protects photoreceptors from PQ-induced apo-
ptosis,8 if increased ceramide levels activate PQ-induced apo-
ptosis, DHA should also prevent photoreceptor apoptosis in-
duced by the addition of ceramide. In DHA-supplemented
cultures, either without C2-ceramide, or with dihydroceram-
ide, approximately 25% of photoreceptors were apoptotic. The
addition of C2-ceramide doubled the amount of apoptotic pho-
toreceptors in DHA-lacking cultures; however, when we added
C2-ceramide at day 3 to cultures supplemented with DHA from
day 1, photoreceptor apoptosis was completely blocked (Fig.
9A).
In addition, whereas ceramide markedly reduced the per-
centage of photoreceptors preserving mitochondrial mem-
brane potential, in DHA-supplemented cultures, mitochondrial
depolarization was prevented, despite ceramide addition (Fig.
9B). Hence, the protective effect of DHA on photoreceptors
correlated with its preservation of their mitochondrial mem-
brane potential.
Effect of DHA on Bcl-2 Expression
in Photoreceptors
We have shown that DHA upregulates the expression of Bcl-2
in photoreceptors.8 We investigated in the present study
whether ceramide treatment blocks the increase in Bcl-2 ex-
pression or whether this increase also participates in the DHA-
protective effect on ceramide-induced apoptosis. Evaluation of
Bcl-2 expression in cultures without or with DHA showed that
DHA increased Bcl-2 levels in every culture condition (Fig. 10).
DHA-lacking cultures (), treated with the vehicle used for
ceramide addition, with 10 M dihydroceramide or with 10
M C2-ceramide showed approximately 36% of photorecep-
tors expressing Bcl-2. In DHA-supplemented cultures, this per-
centage increased to approximately 60% of the total photore-
ceptors, either with or without C2-ceramide (Fig. 10). Hence,
DHA upregulation of Bcl-2 levels persisted despite ceramide
addition, probably contributing to the antiapoptotic effect of
DHA.
Inhibition of Ceramide Glucosylation and DHA’s
Antiapoptotic Effect
The intracellular levels of ceramide depend on the balance
between its production and its further metabolization. Cer-
amide may be glucosylated through the activity of glucosylce-
FIGURE 7. Protective effect of cycloserine on PQ-induced apoptosis of
photoreceptors. Three-day neuronal cultures were left untreated ()
or were supplemented with 0.25 mM cycloserine (CyS), and, after 2
hours, they were treated with PQ (CySPQ) for 24 hours. (A) The
percentage of apoptotic photoreceptors and (B) the percentage of
photoreceptors preserving mitochondrial membrane potential was de-
termined. *Statistically significant difference, compared with the con-
trol (P  0.05).
FIGURE 8. FB prevention of photoreceptor apoptosis during develop-
ment in vitro. Cultures were left without (A, B) or treated with (C, D)
FB, 3 hours after the cells were seeded and then incubated for 6 days.
(A, C) Phase micrographs showing apoptotic (arrows) and surviving
(arrowheads) photoreceptors. (B, D) Fluorescence micrographs
showing nuclei labeled with DAPI. (E) The percentage of apoptotic
photoreceptors in control () and FB-supplemented (FB) cultures.
*Statistically significant difference, compared with the control (P 
0.05). Scale bar, 10 m.
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ramide synthase, with increased glucosylation leading to a
decrease in the size of the ceramide pool, thus reducing the
deleterious effects of ceramide. To investigate whether glu-
cosylceramide synthase participates in DHA protection against
ceramide-induced photoreceptor apoptosis, we added PPMP,
an inhibitor of this enzyme, to neuronal cultures, with or
without DHA, before C2-ceramide treatment. Addition of PPMP
alone had no deleterious effect on neuronal cultures, the
amount of apoptotic photoreceptors in these cultures being
the same as in the control (Fig. 11A). Addition of PPMP fol-
lowed by ceramide treatment did not increase photoreceptor
apoptosis in DHA-lacking cultures, suggesting that this activity
was negligible in cultures without DHA and hence did not
contribute to the decrease in ceramide levels. On the contrary,
DHA protection completely disappeared in cultures to which
PPMP was added before ceramide treatment (Fig. 11A). In
DHA-supplemented cultures without PPMP,25% of total pho-
toreceptors were apoptotic after ceramide addition. With
PPMP, this percentage rose to more than 45%, the same as in
cultures lacking DHA, with a parallel decrease of the amount of
photoreceptors having intact mitochondria (not shown). PPMP
did not affect amacrine cell apoptosis on C2-ceramide treat-
ment, either in DHA-lacking or DHA-supplemented cultures
(not shown). This suggests that inhibiting ceramide glucosyla-
tion abolishes the protective effect of DHA and, conversely,
that DHA promotes ceramide glucosylation, hence decreasing
ceramide levels, and this decrease prevents photoreceptor
apoptosis.
DHA protects photoreceptors from PQ-induced apoptosis.8
If PQ triggered neuronal death by increasing ceramide produc-
tion and DHA prevented death by stimulating ceramide glu-
cosylation, addition of PPMP would diminish the protective
effect of DHA. When DHA-supplemented cultures were treated
with PPMP and 30 minutes later with PQ, DHA’s antiapoptotic
effect was almost completely inhibited by PPMP (Fig. 11B).
The amount of apoptotic photoreceptors in PPMP and PQ-
treated cultures was the same in cultures with or without DHA,
a finding that supports the hypothesis that ceramide accumu-
lation leads to oxidative stress-induced photoreceptor apopto-
sis and strongly suggests that an increase in ceramide glucosy-
lation is a critical DHA-activated mechanism to prevent
ceramide induction of apoptosis.
DISCUSSION
Activation of Photoreceptor Apoptosis by an
Increase in Intracellular Ceramide Levels
Ceramide has been proposed as a signaling molecule involved
in the induction of cell death by oxidative stress. Exogenous
oxidants or conditions that increase the intracellular levels of
reactive oxygen species also increase ceramide production,
whereas inhibition of this increase prevents the generation of
ceramide.46 Modulation of enzymes involved in ceramide syn-
thesis and degradation suppress retinal degeneration and facil-
itate endocytosis in Drosophila mutants35,47; however, direct
evidence of ceramide involvement in photoreceptor death in
mammalian retina was lacking. Our results show that ceramide
accumulation triggered apoptosis in photoreceptors subjected
to oxidative stress. Several lines of evidence support this con-
clusion. An exogenously induced increase in ceramide levels,
through addition of C2-ceramide, activated neuronal death. The
involvement of endogenous generation of ceramide in the
FIGURE 9. DHA protection of photoreceptors from apoptosis induced
by C2-ceramide. Cultures were supplemented at day 1 in vitro with 6.7
M DHA (DHA), complexed with bovine serum albumin (BSA), or
with the same volume of the BSA solution (DHA). At day 3, they were
treated with 10 M C2-ceramide (Cer) or dihydroceramide (DHC), or
the vehicle used for preparing the sphingolipid solutions () for 24
hours. (A) Percentage of apoptotic photoreceptors and (B) of photo-
receptors preserving mitochondrial membrane potential, determined
as previously described. *Statistically significant difference, compared
with the control (P  0.05).
FIGURE 10. Upregulation of Bcl-2 expression in photoreceptors by
DHA supplementation. Cultures supplemented at day 1 in vitro with
DHA (DHA) or with the same volume of a BSA solution (DHA)
treated at day 3 with C2-ceramide (Cer), dihydroceramide (DHC), or
the vehicle used for preparing the sphingolipid solutions (). Bcl-2
expression was determined by immunocytochemistry, using a specific
monoclonal antibody. Bars depict the amount of photoreceptors ex-
pressing Bcl-2 with respect to the total amount of photoreceptors.
*Statistically significant difference, compared with the control (P 
0.05).
IOVS, April 2006, Vol. 47, No. 4 Ceramide as a Mediator of Photoreceptor Apoptosis 1665
induction of apoptosis in photoreceptors was clearly evident in
the rapid accumulation of newly made [3H]ceramide in pho-
toreceptors after PQ treatment in cultures labeled with
[3H]palmitate, which preceded the onset of apoptosis. Inhibi-
tion of ceramide synthesis with both cycloserine and FB com-
pletely blocked PQ-induced photoreceptor apoptosis, demon-
strating that an increase in ceramide is critical for triggering
apoptosis. The presence of these inhibitors left the oxidant
unable to induce photoreceptor apoptosis, revealing that cer-
amide was an essential mediator in the death process. More-
over, DHA, which protects photoreceptors from oxidative
stress8 and ceramide exogenous addition, reduced ceramide
accumulation to promote survival. Inhibition of glucosylation
of ceramide, with the subsequent accumulation of ceramide,
led to the loss of the protective effect of DHA. As a whole,
these results strongly support that an increase in ceramide
intracellular levels is involved in the activation of photorecep-
tor apoptosis and, conversely, inhibition of this increase can
prevent photoreceptor apoptosis on oxidative stress.
Oxidative stress has been shown to increase ceramide pro-
duction by both sphingomyelin hydrolysis46 and de novo bio-
synthesis.48 Our findings suggest that in photoreceptors, oxi-
dative stress increased ceramide endogenous levels by
stimulating the de novo biosynthetic pathway. PQ induced a
rapid accumulation of [3H]ceramide, whereas radioactive
sphingomyelin levels were much lower than those of ceramide
and did not change after addition of PQ, suggesting that cer-
amide is not produced from the breakdown of sphingomyelin.
The addition of two inhibitors of ceramide de novo synthesis,
FB and cycloserine, which block different steps of the de novo
pathway, just before PQ treatment was sufficient to inhibit
photoreceptor apoptosis completely. These results strongly
support that oxidative stress increases ceramide production
through stimulation of the de novo pathway.
Of note, inhibition of ceramide synthesis also rescued pho-
toreceptors from apoptosis during their early development in
vitro. Previous work from our laboratory has shown that after
4 days in culture, photoreceptors start to die through an apo-
ptotic pathway, and this death may be postponed by trophic
factors such as DHA.9,10,16,38 In the present study, even in the
absence of trophic factors, inhibiting ceramide synthesis was
sufficient to reduce photoreceptor apoptosis markedly. This
suggests that an increase in ceramide production may contrib-
ute to photoreceptor death in the absence of trophic factors,
and strongly supports that ceramide may be a common medi-
ator of photoreceptor apoptosis in different situations of cel-
lular stress.
Addition of C2-ceramide also induced the apoptosis of am-
acrine cells. However, endogenous ceramide involvement in
the activation of amacrine cell death seemed less critical than
in photoreceptors. The addition of FB at day 0 only partially
reduced amacrine cell apoptosis after PQ treatment, and its
addition at day 3 did not prevent it at all. Amacrine cells
comprise more than 20 subtypes,49 and several of them coexist
in vitro. Our results suggest that either ceramide is not the
principal mediator in the activation of apoptosis in amacrine
neurons or it participates only in the induction of apoptosis in
one amacrine cell subtype or a few. Moreover, because only
early addition of FB had a protective effect, the increase in
ceramide leading to apoptosis in some amacrine cells may arise
from sphingomyelin hydrolysis. The different effect of inhibi-
tors of ceramide synthesis in photoreceptor and amacrine cell
death suggests that distinct synthetic pathways lead to cer-
amide production in each cell type.
Apoptosis induced by ceramide involved the mitochondrial
pathway, because C2-ceramide led to a loss of mitochondrial
membrane potential in photoreceptors and amacrine neurons,
and this loss was prevented by inhibition of ceramide synthe-
sis. Mitochondria are well-known targets of ceramide,50 which
induces generation of ROSs51,52 and leads to mitochondrial
perturbations and function loss.29,53,54 An increase in ceramide
increase and mitochondrial depolarization are closely con-
nected. Inhibiting mitochondrial depolarization significantly
reduces ceramide-induced cell death,55 whereas blocking C16-
ceramide synthesis prevents mitochondrial depolarization and
nuclear fragmentation.56 Ceramide induces the release of pro-
apoptotic mitochondrial proteins,57–60 leading to activation of
caspases. Our results suggest that an increase in ceramide
preceded the loss of mitochondrial integrity and was involved
in triggering this loss.
Effect of DHA on Ceramide-Induced Apoptosis
DHA prevents the apoptosis of photoreceptors both during
their early development in culture and that induced by oxida-
FIGURE 11. Effect of inhibition of glucosylceramide synthase on DHA
protection of photoreceptors. Cultures supplemented at day 1 in vitro
with DHA or with a BSA solution () were treated at day 3 with
(PPMP) or without (PPMP) 10 M PPMP, an inhibitor of glucosyl-
ceramide synthase. Thirty minutes later, cultures were treated either
(A) with 10 M C2-ceramide (Cer, DHACer) or (B) with 48 M PQ
(DHAPQ). After a 24-hour incubation, the percentage of apoptotic
photoreceptors in each experimental condition was determined. *Sta-
tistically significant difference, compared with the control (P  0.05).
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tive stress.8–10,16,38 We have shown that DHA enhances the
expression of the antiapoptotic protein Bcl-2 in photorecep-
tors, an increase that still stood in PQ-treated cultures in the
current study.8 Consistent with the hypothesis that ceramide is
the main mediator in oxidative stress–induced apoptosis of
photoreceptors, DHA also precluded apoptosis triggered by
exogenous addition of ceramide in these cells. As with PQ, this
protection involved the pronounced upregulation of Bcl-2 ex-
pression, unaffected by ceramide addition, and prevention of
the loss of integrity of the mitochondrial membrane. Overex-
pression of Bcl-2 interferes with the ceramide pathway.29,61,62
Bcl-2 has been proposed to act at two levels: upstream of
ceramide synthesis or downstream, preventing cytochrome c
release in isolated mitochondria59 and inhibiting caspase acti-
vation.63 Because increased Bcl-2 contributes to photoreceptor
survival on addition of exogenous ceramide, our results sug-
gest that it acts at least downstream of ceramide production,
probably preventing the release of death-inducing factors from
mitochondria.
DHA has recently been shown to induce a differential tran-
scription in several genes in fetal human retina,64 among them
the gene coding for glucosylceramide synthase. By promoting
ceramide glucosylation, this enzymatic activity decreases cer-
amide levels, and consequently, its inhibition mimics many of
the effects of directly increasing intracellular ceramide concen-
trations.65 Conversely, an increased synthesis and accumula-
tion of glucosylceramide has been associated with drug resis-
tance in several cancer cell lines.66,67 Inhibiting the activity of
this enzyme abolished DHA protection after C2-Cer and PQ
treatment. This suggests that an increase in the synthesis or
activity of glucosylceramide synthase was involved in DHA’s
antiapoptotic effect. Inhibiting this enzyme was also sufficient
to block DHA protection of photoreceptors on oxidative stress.
This supports the proposal that oxidative stress leads to an
increased production of ceramide, and this increase triggers
apoptosis. DHA, by enhancing ceramide glucosylation, hin-
dered its accumulation, thus blocking the initiation of apopto-
sis. These results also suggest that an increase in Bcl-2 expres-
sion is not sufficient to guarantee photoreceptor cell survival.
The decrease in ceramide accumulation by its increased glu-
cosylation is indispensable in the protective effect of DHA.
Our findings suggest that ceramide plays a key role in the
induction of photoreceptor apoptosis. Oxidative stress in-
creased ceramide production by de novo biosynthesis, and this
increase signaled photoreceptor apoptosis. Diminishing cer-
amide accumulation, either by inhibiting its synthesis or by
promoting its metabolization prevented photoreceptor death.
Regulation of ceramide levels was crucial for DHA protection,
which involved a combination of mechanisms. DHA upregu-
lated Bcl-2 expression, and simultaneously diminished cer-
amide accumulation. As a whole, these results suggest that
modulating the activity of the enzymes involved in sphingo-
lipid metabolism may provide a therapeutic tool for preventing
photoreceptor death in retinal neurodegenerative diseases.
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